Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.

scientific article published on 19 May 2006

Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VIROL.2006.03.046
P698PubMed publication ID16712895

P50authorJoan PujolsQ42593202
Laila DarwichQ45382470
Ivan DíazQ56810275
P2093author name stringMateu E
Pappaterra G
P2860cites workThe molecular biology of arterivirusesQ56897174
Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigensQ57207509
Strategies to control PRRS: a summary of field and research experiencesQ73504875
Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine developmentQ33930291
The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus loadQ34151395
The immune response to equine arteritis virus: potential lessons for other arterivirusesQ35928792
Role of neutralizing antibodies in PRRSV protective immunityQ35928806
Use of ELISPOT and ELISA to evaluate IFN-gamma, IL-10 and IL-4 responses in conventional pigsQ40420514
Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virusQ40566308
Molecular characterization of Lelystad virus.Q40652369
A molecular clock dates the common ancestor of European-type porcine reproductive and respiratory syndrome virus at more than 10 years before the emergence of diseaseQ40678409
Slow-reacting and complement-requiring neutralizing antibody in swine infected with porcine reproductive and respiratory syndrome (PRRS) virusQ41177883
A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine seraQ41458833
Mystery swine disease in the Netherlands: The isolation of Lelystad virusQ41677026
Examination of the selective pressures on a live PRRS vaccine virusQ42618488
Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus groupQ42619566
Phylogenetic analyses of the putative M (ORF 6) and N (ORF 7) genes of porcine reproductive and respiratory syndrome virus (PRRSV): implication for the existence of two genotypes of PRRSV in the U.S.A. and EuropeQ42686832
Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant miceQ45049439
Immune responses of pigs after experimental infection with a European strain of Porcine reproductive and respiratory syndrome virusQ45447879
Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herdsQ45462836
New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV).Q45490280
Pathogenic and humoral immune responses to porcine reproductive and respiratory syndrome virus (PRRSV) are related to viral load in acute infectionQ45559476
Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacyQ45567949
Genomic characterization of virulent, attenuated, and revertant passages of a North American porcine reproductive and respiratory syndrome virus strain.Q45658151
Parameters of Humoral and Cellular Immunity Following Vaccination of Pigs with a European Modified-Live Strain of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)Q45710615
Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virusQ45718490
Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccinesQ45722116
Expression of interleukin-10 and interleukin-12 in piglets experimentally infected with porcine reproductive and respiratory syndrome virus (PRRSV).Q45722199
Gradual development of the interferon-γ response of swine to porcine reproductive and respiratory syndrome virus infection or vaccinationQ45723769
Genetic diversity and phylogenetic analysis of glycoprotein 5 of European-type porcine reproductive and respiratory virus strains in SpainQ45729017
Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virusQ45729116
Risk factors for infection of sow herds with porcine reproductive and respiratory syndrome (PRRS) virusQ45733896
Elevated serum haptoglobin in pigs infected with porcine reproductive and respiratory syndrome virusQ45746951
Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicityQ45748123
Effect on viraemia of an American and a European serotype PRRSV vaccine after challenge with European wild-type strains of the virusQ45755668
Efficacy of an inactivated vaccine for prevention of reproductive failure induced by porcine reproductive and respiratory syndrome virusQ45761816
Characterization of the Humoral Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Virus InfectionQ45788537
Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responsesQ45844085
The 2b protein as a minor structural component of PRRSV.Q47747498
Deciphering the involvement of innate immune factors in the development of the host response to PRRSV vaccinationQ47905938
Comparative safety and efficacy of attenuated single-strain and multi-strain vaccines for porcine reproductive and respiratory syndrome.Q51685719
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectporcine reproductive and respiratory syndrome virusQ1760147
porcine reproductive and respiratory syndromeQ2275037
P304page(s)249-259
P577publication date2006-05-19
P1433published inVirologyQ7934867
P1476titleDifferent European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs
P478volume351

Reverse relations

cites work (P2860)
Q93048878A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection
Q41450592A comparative study of the local cytokine response in the lungs of pigs experimentally infected with different PRRSV-1 strains: upregulation of IL-1α in highly pathogenic strain induced lesions
Q44962786A modified live PRRSV vaccine and the pathogenic parent strain induce regulatory T cells in pigs naturally infected with Mycoplasma hyopneumoniae
Q34260827A new modified live porcine reproductive and respiratory syndrome vaccine improves growth performance in pigs under field conditions
Q35089195Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge
Q39705319Assessment of safety and reproductive performance after vaccination with a modified live-virus PRRS genotype 1 vaccine in pregnant sows at various stages of gestation
Q40615914Attempts to enhance cross-protection against porcine reproductive and respiratory syndrome viruses using chimeric viruses containing structural genes from two antigenically distinct strains.
Q40058547Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence
Q35116494Boosting in planta production of antigens derived from the porcine reproductive and respiratory syndrome virus (PRRSV) and subsequent evaluation of their immunogenicity
Q89518998Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2
Q37775727Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology.
Q37493297Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology
Q34121223Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus
Q42248007Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection
Q40125239Characterization of immune responses following homologous reinfection of pigs with European subtype 1 and 3 porcine reproductive and respiratory syndrome virus strains that differ in virulence
Q40272313Comparative analysis of immune responses following experimental infection of pigs with European porcine reproductive and respiratory syndrome virus strains of differing virulence
Q36905803Comparative expression of Toll-like receptors and inflammatory cytokines in pigs infected with different virulent porcine reproductive and respiratory syndrome virus isolates
Q44808944Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
Q34432119Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges
Q45382031Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus
Q34569610Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates
Q42224953Cytokines transcript levels in lung and lymphoid organs during genotype 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection
Q39478449Development of a DNA-launched replicon as a vaccine for porcine reproductive and respiratory syndrome virus.
Q40790895Differences of immune responses between Tongcheng (Chinese local breed) and Large White pigs after artificial infection with highly pathogenic porcine reproductive and respiratory syndrome virus
Q38441596Distinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV).
Q40298624Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine.
Q45323989Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs
Q45384517Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Q40973523Efficacy of combined vaccination against Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus in dually infected pigs.
Q45359135Enhanced expression of TGFβ protein in lymphoid organs and lung, but not in serum, of pigs infected with a European field isolate of porcine reproductive and respiratory syndrome virus.
Q40695891Establishing Porcine Monocyte-Derived Macrophage and Dendritic Cell Systems for Studying the Interaction with PRRSV-1.
Q61473737European genotype of porcine reproductive and respiratory syndrome (PRRSV) infects monocyte-derived dendritic cells but does not induce Treg cells
Q90437990Evaluation of PRRSv specific, maternally derived and induced immune response in Ingelvac PRRSFLEX EU vaccinated piglets in the presence of maternally transferred immunity
Q37203209Evaluation of the Cross-Protective Efficacy of a Chimeric Porcine Reproductive and Respiratory Syndrome Virus Constructed Based on Two Field Strains.
Q42209705Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge
Q41781830Functional impairment of PRRSV-specific peripheral CD3+CD8high cells
Q45384291GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge
Q42260304Genetic and antigenic characterization of complete genomes of Type 1 Porcine Reproductive and Respiratory Syndrome viruses (PRRSV) isolated in Denmark over a period of 10 years
Q45357815Gp96 enhances the immunogenicity of subunit vaccine of porcine reproductive and respiratory syndrome virus
Q45367705Identification of immunodominant T-cell epitopes in membrane protein of highly pathogenic porcine reproductive and respiratory syndrome virus
Q38668708Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward
Q61801298Immune response development after vaccination of 1-day-old naïve pigs with a Porcine Reproductive and Respiratory Syndrome 1-based modified live virus vaccine
Q45366240Immune responses in piglets infected with highly pathogenic porcine reproductive and respiratory syndrome virus
Q38971626Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
Q82416184Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant
Q45355535Immunohistochemical expression of IL-12, IL-10, IFN-α and IFN-γ in lymphoid organs of porcine reproductive and respiratory syndrome virus-infected pigs
Q37934055Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS).
Q38069683Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs.
Q40046407Improved Vaccine against PRRSV: Current Progress and Future Perspective
Q45382377In silico prediction and ex vivo evaluation of potential T-cell epitopes in glycoproteins 4 and 5 and nucleocapsid protein of genotype-I (European) of porcine reproductive and respiratory syndrome virus
Q59793645In vitro immune responses of porcine alveolar macrophages reflect host immune responses against porcine reproductive and respiratory syndrome viruses
Q43543311Induction of T helper 3 regulatory cells by dendritic cells infected with porcine reproductive and respiratory syndrome virus
Q30410415Interaction between innate immunity and porcine reproductive and respiratory syndrome virus
Q44335250Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus.
Q45353543Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from
Q37775279Modulation of host cell responses and evasion strategies for porcine reproductive and respiratory syndrome virus
Q40656239Molecular epidemiology of porcine reproductive and respiratory syndrome viruses isolated from 1991 to 2013 in Taiwan
Q34269264Mycobacterium tuberculosis whole cell lysate enhances proliferation of CD8 positive lymphocytes and nitric oxide secretion in the lungs of live porcine respiratory and reproductive syndrome virus vaccinated pigs
Q39320224N-linked glycosylation of GP5 of porcine reproductive and respiratory syndrome virus is critically important for virus replication in vivo
Q30235375Next-generation sequencing as a tool for the study of Porcine reproductive and respiratory syndrome virus (PRRSV) macro- and micro- molecular epidemiology.
Q40916154PD-L1 expression is increased in monocyte derived dendritic cells in response to porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus infections
Q37249703Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus
Q44111791Phenotypic and functional modulation of bone marrow-derived dendritic cells by porcine reproductive and respiratory syndrome virus
Q34646875Pig immune response to general stimulus and to porcine reproductive and respiratory syndrome virus infection: a meta-analysis approach
Q47219938Plant synthetic GP4 and GP5 proteins from porcine reproductive and respiratory syndrome virus elicit immune responses in pigs
Q45352118Plasmids expressing porcine interferon gamma up-regulate pro-inflammatory cytokine and co-stimulatory molecule expression which are suppressed by porcine reproductive and respiratory syndrome virus
Q30364184Porcine reproductive and respiratory syndrome (PRRS): an immune dysregulatory pandemic.
Q44453997Porcine reproductive and respiratory syndrome virus induces CD4+CD8+CD25+Foxp3+ regulatory T cells (Tregs).
Q39274756Porcine reproductive and respiratory syndrome virus induces pronounced immune modulatory responses at mucosal tissues in the parental vaccine strain VR2332 infected pigs
Q42071929Porcine reproductive and respiratory syndrome virus infects mature porcine dendritic cells and up-regulates interleukin-10 production
Q38076180Porcine reproductive and respiratory syndrome virus vaccines: current status and strategies to a universal vaccine
Q38597798Positive effects of porcine IL-2 and IL-4 on virus-specific immune responses induced by the porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 DNA vaccine in swine
Q40259551Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.
Q35124260RNA-sequence analysis of primary alveolar macrophages after in vitro infection with porcine reproductive and respiratory syndrome virus strains of differing virulence
Q42236586Regulation of toll-like receptors 3, 7 and 9 in porcine alveolar macrophages by different genotype 1 strains of porcine reproductive and respiratory syndrome virus.
Q27001221Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?
Q36286076Rescue and evaluation of a recombinant PRRSV expressing porcine Interleukin-4.
Q28071014Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination
Q34433140Risk factors for porcine reproductive and respiratory syndrome virus infection and resulting challenges for effective disease surveillance.
Q58760019Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region
Q64090850Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against and an inactivated vaccine against and in breeding pigs
Q40520410Strategies to broaden the cross-protective efficacy of vaccines against porcine reproductive and respiratory syndrome virus.
Q36286619Suppression of immune responses in pigs by nonstructural protein 1 of porcine reproductive and respiratory syndrome virus
Q45352700Synthetic B- and T-cell epitope peptides of porcine reproductive and respiratory syndrome virus with Gp96 as adjuvant induced humoral and cell-mediated immunity
Q35784569The 15N and 46R Residues of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Enhance Regulatory T Lymphocytes Proliferation
Q36888431The challenge of PRRS immunology.
Q45357557Type 2 Porcine Reproductive and Respiratory Syndrome Virus infection mediated apoptosis in B- and T-cell areas in lymphoid organs of experimentally infected pigs.
Q53729326Vaccination of piglets at 2 and 3 weeks of age with Ingelvac PRRSFLEX® EU provides protection against heterologous field challenge in the face of homologous maternally derived antibodies.
Q37582096Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation
Q37769862Vectored vaccines to protect against PRRSV.

Search more.